Skip to main content
Fig. 2 | BMC Complementary Medicine and Therapies

Fig. 2

From: Combination of Quercetin or/and siRNA-loaded DDAB-mPEG-PCL hybrid nanoparticles reverse resistance to Regorafenib in colon cancer cells

Fig. 2

 A Dose- response survival of LS-180 cells after exposure to increasing concentrations of Regorafenib for 24 h; B Dose- response survival of resistance LS-180 cells after exposure to increasing concentrations of Regorafenib for 24 h; C Dose- response survival of LS-180 cells after exposure to increasing concentrations of Quercetin for 24 h; D Dose- response survival of resistance LS-180 cells after exposure to increasing concentrations of Regorafenib for 24 h

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us